Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody
- PMID: 1385471
- DOI: 10.1016/0165-5728(92)90136-9
Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody
Abstract
A chronic relapsing model of demyelinating experimental allergic encephalomyelitis (EAE) was induced in Lewis rats by the repeated co-transfer of encephalitogenic, myelin basic protein (MBP)-specific T cells in combination with a demyelinating monoclonal antibody (mAb) specific for the myelin oligodendrocyte glycoprotein (MOG). In controls, repeated injections of 5 x 10(5) MBP-specific T cells at intervals of 18-21 days resulted in an increasing resistance to the induction of further episodes of EAE. However, intravenous injection of the mAb 4 days after each T cell transfer overcame this 'vaccination' effect and induced severe clinical relapses associated with an increasing and persistent neurological deficit. Histological examination revealed that four cycles of treatment with T cells and mAb were sufficient to result in the formation of large plaques of demyelination in the spinal cord that failed to undergo significant remyelination within 60 days of the final injection of mAb. These lesions consisted of a matrix of astrocytic scar tissue traversed by numerous naked axons. These observations demonstrate that the formation of large, persistently, demyelinated lesions in a T cell-mediated model of EAE in the Lewis rat is dependent on the presence of an appropriate anti-myelin autoantibody response.
Similar articles
-
Induction of hyperacute brain inflammation and demyelination by activated encephalitogenic T cells and a monoclonal antibody specific for a myelin/oligodendrocyte glycoprotein.Autoimmunity. 1989;2(3):265-73. doi: 10.3109/08916938909014690. Autoimmunity. 1989. PMID: 2491610
-
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.Eur J Immunol. 1993 Jun;23(6):1364-72. doi: 10.1002/eji.1830230627. Eur J Immunol. 1993. PMID: 7684687
-
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.J Neuroimmunol. 1995 Dec;63(1):17-27. doi: 10.1016/0165-5728(95)00124-7. J Neuroimmunol. 1995. PMID: 8557821
-
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.J Mol Med (Berl). 1997 Feb;75(2):77-88. doi: 10.1007/s001090050092. J Mol Med (Berl). 1997. PMID: 9083925 Review.
-
Animal models.Ann Neurol. 1994;36 Suppl:S47-53. doi: 10.1002/ana.410360714. Ann Neurol. 1994. PMID: 7517126 Review.
Cited by
-
Delimiting MOGAD as a disease entity using translational imaging.Front Neurol. 2023 Dec 7;14:1216477. doi: 10.3389/fneur.2023.1216477. eCollection 2023. Front Neurol. 2023. PMID: 38333186 Free PMC article. Review.
-
B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity.J Exp Med. 2002 Nov 18;196(10):1277-90. doi: 10.1084/jem.20020649. J Exp Med. 2002. PMID: 12438420 Free PMC article.
-
A gene therapy approach to treatment of autoimmune disease.Immunol Res. 1998 Aug;18(1):15-26. doi: 10.1007/BF02786510. Immunol Res. 1998. PMID: 9724846 Review.
-
Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.Brain Pathol. 2007 Apr;17(2):219-29. doi: 10.1111/j.1750-3639.2007.00065.x. Brain Pathol. 2007. PMID: 17388953 Free PMC article. Review.
-
Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.J Clin Immunol. 2001 May;21(3):155-70. doi: 10.1023/a:1011031014433. J Clin Immunol. 2001. PMID: 11403222 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous